J. Safra Sarasin Holding’s AbbVie ABBV Stock Holding History

J. Safra Sarasin Holding’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$77.4M	Buy	342,816 +5,849	+2%	+$1.26M	1.11%	18
2026 Q1	$73.3M	Buy	336,967 +25,665	+8%	+$5.69M	1.25%	18
2025 Q4	$71.1M	Sell	311,302 -36,172	-10%	-$8.24M	1.16%	20
2025 Q3	$80.4M	Buy	347,474 +62,723	+22%	+$12.8M	1.3%	18
2025 Q2	$52.8M	Buy	284,751 +149,378	+110%	+$27.8M	0.91%	37
2025 Q1	$28.3M	Buy	135,373 +95,460	+239%	+$18.6M	0.51%	57
2024 Q4	$7.08M	Buy	39,913 +19,863	+99%	+$3.65M	0.12%	123
2024 Q3	$3.94M	Sell	20,050 -40	-0.2%	-$7.46K	0.07%	150
2024 Q2	$3.45M	Buy	+20,090	New	+$3.33M	0.06%	164

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

J. Safra Sarasin Holding's ABBV Position: Q2 2026 in Review

J. Safra Sarasin Holding increased its AbbVie (ABBV) stake by 1.7% in Q2 2026, buying an estimated $1.26M and bringing the position to 342,816 shares worth $77.4M. The position accounts for 1.11% of the portfolio, ranked #18.

J. Safra Sarasin Holding first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. The position peaked at $80.4M in Q3 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

J. Safra Sarasin Holding held 342,816 shares of AbbVie worth $77.4M as of Q2 2026.
J. Safra Sarasin Holding bought 5,849 AbbVie shares in Q2 2026, an estimated $1.26M.
AbbVie made up 1.11% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #18 holding.
J. Safra Sarasin Holding first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
J. Safra Sarasin Holding's AbbVie position peaked at $80.4M in Q3 2025.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.